HBM Holdings Limited

DB:6XY Stock Report

Market Cap: €117.3m

HBM Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jingsong Wang

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage55.8%
CEO tenure8.4yrs
CEO ownership8.4%
Management average tenureless than a year
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jingsong Wang's remuneration changed compared to HBM Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

US$21m

Mar 31 2024n/an/a

US$22m

Dec 31 2023US$2mUS$885k

US$23m

Sep 30 2023n/an/a

-US$19m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$99m

Dec 31 2022US$2mUS$781k

-US$137m

Sep 30 2022n/an/a

-US$143m

Jun 30 2022n/an/a

-US$149m

Mar 31 2022n/an/a

-US$144m

Dec 31 2021US$13mUS$13m

-US$138m

Sep 30 2021n/an/a

-US$224m

Jun 30 2021n/an/a

-US$310m

Mar 31 2021n/an/a

-US$303m

Dec 31 2020US$21mUS$654k

-US$296m

Compensation vs Market: Jingsong's total compensation ($USD1.59M) is above average for companies of similar size in the German market ($USD470.78K).

Compensation vs Earnings: Jingsong's compensation has been consistent with company performance over the past year.

CEO

Jingsong Wang (59 yo)

8.4yrs

Tenure

US$1,585,000

Compensation

Dr. Jingsong Wang M.D., Ph D., serves as Chairman of Board of Directors of HBM Alpha Therapeutics, Inc. He has been Chief Executive Officer of HBM Holdings Limited and Harbour BioMed Shanghai Co., Ltd. sin...

Leadership Team

NamePositionTenureCompensationOwnership
Jingsong Wang
Founderno dataUS$1.59m8.43%
€ 9.9m
Yiping Rong
Chief Scientific Officer & Executive Director2yrsUS$547.00k0.028%
€ 32.7k
Youchen Chen
VP, Head of Finance & Investor Relationsless than a yearno datano data
Bruce Zhang
VP & Head of Legal Affairsno datano datano data
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno datano datano data
Xiaolu Tao
Chief Development Officerno datano datano data
Steve Arkinstall
Chief Scientific Advisor1.5yrsno datano data
Ben Chih
Chief Scientific Officer of Neurosciences - Harbour BioMed USless than a yearno datano data
Michael Lee
Senior VP & Head of Biometricsless than a yearno datano data
Amy Jiang
VP, Chief of Staff & Head of Quality Departmentless than a yearno datano data
Yuanqing Wei
VP & Head of Translational Developmentless than a yearno datano data
Raymond Zheng
Chief Business Officerless than a yearno datano data

0.4yrs

Average Tenure

50yo

Average Age

Experienced Management: 6XY's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jingsong Wang
Founder8.4yrsUS$1.59m8.43%
€ 9.9m
Yiping Rong
Chief Scientific Officer & Executive Director2.6yrsUS$547.00k0.028%
€ 32.7k
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno datano datano data
Robert Kamen
Independent Non-Executive Director & Member of Scientific Advisory Board8yrsUS$50.00k0.36%
€ 420.5k
Albert R. Collinson
Independent Non-Executive Director1.4yrsUS$21.00kno data
Alexander A. Zukiwski
Member of Scientific Advisory Board2.6yrsno datano data
Xiaoping Ye
Independent Non-Executive Director4.1yrsUS$50.00kno data
Jon Marc Wigginton
Member of Scientific Advisory Board4.5yrsno datano data
Robert Kramer
Member of Scientific Advisory Board8yrsno datano data
Frank Grosveld
Member of Scientific Advisory Board8yrsno datano data
Weiwei Chen
Senior Business Adviser & Non-Executive Director4.1yrsUS$50.00kno data
Zhigang Tian
Member of Scientific Advisory Board4.3yrsno datano data

4.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 6XY's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 11:53
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HBM Holdings Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Tony RenCLSA
null nullCredit Suisse